ATECHealthcare · Medical DevicesThe 14 Wall Street analysts covering Alphatec Holdings, Inc. hold a median 12-month price target of $15 — +58.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 76 of 100 as at 21 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Alphatec Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (91): The business earns solid, repeatable profits on what it owns.
Issuance (25): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ATEC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +58.2% from it.
Of the 20 most recent actions, 3 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 5 Aug 2026 | BMO Capital | Maintains | Outperform | $11 → $12 |
| 5 Aug 2026 | TD Cowen | Maintains | Buy | $11 → $13 |
| 5 Aug 2026 | UBS | Maintains | Buy | $15 → $16 |
| 28 July 2026 | UBS | Initiates | Buy | $15 |
| 28 July 2026 | UBS | Initiates | Buy | — |
| 23 July 2026 | Stephens & Co. | Initiates | Overweight | $15 |
| 23 July 2026 | Stephens & Co. | Initiates | Overweight | — |
| 9 July 2026 | BMO Capital | Initiates | Outperform | $11 |
| 9 July 2026 | BMO Capital | Initiates | Outperform | — |
| 8 July 2026 | Stifel | Maintains | Buy | — |
| 8 July 2026 | Stifel | Maintains | Buy | $16 → $13 |
| 7 May 2026 | Barclays | Maintains | Overweight | — |
| 7 May 2026 | HC Wainwright & Co. | Reiterates | Buy | — |
| 7 May 2026 | Wells Fargo | Maintains | Overweight | — |
| 6 May 2026 | Canaccord Genuity | Maintains | Buy | — |
| 6 May 2026 | JP Morgan | Maintains | Overweight | — |
| 6 May 2026 | Needham | Maintains | Buy | — |
| 6 May 2026 | Piper Sandler | Reiterates | Overweight | — |
| 6 May 2026 | TD Cowen | Maintains | Buy | — |
| 9 Mar 2026 | Stifel | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ATEC appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 93% of US stocks
Cheaper than 57% of US stocks
Cheaper than 99% of US stocks
Cheaper than 5% of US stocks
Higher than 63% of US stocks
Higher than 53% of US stocks
Higher than 85% of US stocks
Higher than 31% of US stocks
Higher than 18% of US stocks
Higher than 4% of US stocks
Higher than 34% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Alphatec Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Alphatec Holdings, Inc. (ATEC) held its Q2 2026 earnings call, the transcript of which was published by Seeking Alpha.
Why it matters — For ATEC watchers, the earnings call transcript provides direct insight into the company's second-quarter performance and management's perspective on the business.
Alphatec (ATEC) reported quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share in the same quarter a year ago.
Why it matters — The earnings came in below the consensus estimate, making it a notable data point for those tracking ATEC's quarterly financial performance.
Alphatec reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier. Growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.
Why it matters — ATEC watchers would care because the results point to accelerating procedure growth and surger adoption translating into stronger profitability and positive free cash flow.
Alphatec Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting total revenue of $214 million, GAAP gross margin of 72.2%, and non-GAAP gross margin of 72.5%.
Why it matters — The results provide a key update on ATEC's financial performance and operational metrics for the most recent quarter.
Alphatec Holdings announced that management will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and the 19th Annual Piper Sandler MedTech conference, hosting investor meetings and a presentation respectively.
Why it matters — The company's participation in these investor conferences signals ongoing engagement with the financial community and provides opportunities for management to communicate its strategy to potential investors.
The 14 Wall Street analysts covering Alphatec Holdings, Inc. have a median 12-month price target of $15, with estimates ranging from $12 to $24. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering Alphatec Holdings, Inc., 14 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Alphatec Holdings, Inc. 76 out of 100 across roughly 4,600 US stocks as at 21 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 21 Aug 2026, Alphatec Holdings, Inc. ranks 76 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (91 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies +58.2% from the last close, and Ticker Nerd's factor model ranks Alphatec Holdings, Inc. 76 out of 100 as at 21 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Alphatec Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ATEC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $12 to $24 over the next 12 months.
Alphatec Holdings, Inc. returned -40.5% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Alphatec Holdings Inc. is a medical technology company specializing in the design, development, and commercialization of surgical solutions for the treatment of spinal disorders.
The most recent item we track (Seeking Alpha, 5 Aug 2026): "Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript". Alphatec Holdings, Inc. (ATEC) held its Q2 2026 earnings call, the transcript of which was published by Seeking Alpha.
Alphatec Holdings Inc. is a medical technology company specializing in the design, development, and commercialization of surgical solutions for the treatment of spinal disorders. It focuses exclusively on spine surgery, offering an integrated ecosystem that includes implants, instruments, imaging systems, neuromonitoring technologies, and biologics to enhance procedural outcomes, reproducibility, and safety. Key platforms encompass the Alpha InformatiX system with EOS imaging for full-body analysis, VEA alignment applications, SafeOp Neural InformatiX for automated monitoring, and advanced procedural approaches like Prone TransPsoas (PTP) and Lateral TransPsoas (LTP). Through subsidiaries such as Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., the company provides solutions for complex thoracolumbar pathologies, including degeneration, deformity, trauma, and tumors. These offerings support procedures like posterior and anterior cervical fusion, lateral and posterior lumbar interbody fusion, and vertebral body replacements with innovative NanoTec surface technology. Headquartered in Carlsbad, California, Alphatec Holdings Inc. serves surgeons and healthcare providers internationally, positioning itself as a leader in data-informed, clinically distinguished spine care.
CEO Mr. Patrick S. Miles · 913 employees · United States · https://www.atecspine.com